483 Vertex Pharmaceuticals Oct 2014

483 Vertex Pharmaceuticals Oct 2014

Camerson Moore FDA$119.00 - Available Now

FDA investigators audited the Vertex Pharmaceuticals - Boston, MA, United States facility and issued 3 inspectional observations (via FDA 483) on 16 Oct 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 16 Oct 2014
  • Location: Boston, United States
  • FEI: 1000513211
Add To Cart